SAN CARLOS, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] today announced that the Company’s proprietary Helix Biotherapeutic Delivery System (the Helix System) demonstrated the best safety profile among clinical transendocardial catheter injection systems used for cardiac cell therapy delivery in an in-press corrected proof published in the journal, Cardiovascular […]
Other News
Cytokinetics Announces Additional Results From GALACTIC-HF to be Presented at the 17th Global Cardiovascular Clinical Trialists Forum
Data from Supplemental Analyses to be Shared at Clinical Trials Think Tank Meeting SOUTH SAN FRANCISCO, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced additional results from GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), the Phase 3 event driven cardiovascular outcomes clinical trial of omecamtiv mecarbil, will be presented at […]
Biotricity Prepares 510(k) FDA Filing for Biotres
Required lab testing complete for Biotres a novel holter patch product REDWOOD CITY, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed required lab testing and is completing its 510(k) FDA filing for its latest potential product […]
iRhythm Technologies Receives Positive National Guidance in First of its Kind Digital Health Pilot with National Institute for Health and Care Excellence
Remote cardiac monitoring service Zio XT has been evaluated and positively recommended by NICE SAN FRANCISCO and UNITED KINGDOM, Dec. 01, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced it is the first technology to pass […]
Arcoma launches new X-ray system OMNERA 500A on the US market
2020-12-01 PRESSRELEASE Arcoma launches new X-ray system OMNERA 500A on the US market Arcoma AB today launches the new X-ray system Omnera 500A on the American market. OMNERA 500A Includes New Intelligent Automation Features to Help Improve Workflow and Efficiency, Without Compromising on Patient Care. The OMNERA 500A offers outstanding […]
Matinas BioPharma Appoints Hui Liu, Ph.D., M.B.A. as Chief Technology Officer
– Dr. Liu brings more than 20 years of expertise in pharmaceutical development, formulation, and CMC, with specific focus on lipid-based delivery of complex molecules – BEDMINSTER, N.J., Dec. 01, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to […]
Jim Andrews Appointed to Biome Analytics Board
Cardiovascular service line executive brings 10 years of senior leadership experience and a proven track record of value creation SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance company announced that they have expanded the Board of Directors with the appointment of Jim Andrews. Andrews is currently senior vice president, cardiac […]
Bayer and Blackford Analysis Announce AI Platform Agreement in Radiology
Bayer and Blackford Analysis have entered into a development and license agreement to establish an artificial intelligence (AI) platform for medical imaging. This agreement supports Bayer’s commitment to expanding its AI capabilities and accelerating innovation in radiology INDIANOLA, Pa.–(BUSINESS WIRE)–During the week of November 29 to December 5, leaders in […]
Vesper Medical Announces First Enrollment in the VIVID Trial
Company Initiates Pivotal Clinical Study for Next Generation Deep Venous Stent MALVERN, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced initiation of its U.S. Food and Drug Administration (FDA) Investigational Exemption (IDE) study – Venous stent for the Iliofemoral Vein Investigational clinical trial using the Vesper DUO Venous […]
First Patients Enrolled in Balt STEM Trial
IRVINE, Calif.–(BUSINESS WIRE)–Balt announced today that the first patients have been enrolled in the clinical trial; The SquidTM Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic subdural hematoma [NCT04410146]. This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for […]
Recent
New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
Popular
- No commented posts yet